Trichomoniasis: Symptoms, Diagnosis, Treatment & Prevention
Comprehensive guide to Trichomoniasis: causes, symptoms, diagnosis, treatment, and prevention of this common STI caused by Trichomonas vaginalis.
Authoritative facts about the clinical features, diagnosis, management, and prevention of trichomoniasis, a common sexually transmitted infection caused by the protozoan parasite Trichomonas vaginalis.
What is trichomoniasis?
Trichomoniasis is a sexually transmitted infection (STI) caused by the protozoan parasite Trichomonas vaginalis. This flagellated parasite primarily infects the urogenital tract, making it one of the most common non-viral STIs worldwide. It affects both men and women, though women are more likely to develop noticeable symptoms. The infection spreads through sexual contact, including vaginal, oral, or anal sex, and can be transmitted even if no symptoms are present. Globally, the World Health Organization estimates millions of cases annually, highlighting its public health significance.
In women, the parasite colonizes the vagina, cervix, and urethra, leading to vaginitis. In men, it typically resides in the urethra, prostate, or epididymis. Unlike bacterial STIs, trichomoniasis is parasitic and requires specific antiprotozoal treatment. Untreated cases can persist for months or years, increasing risks of transmission and complications like preterm birth in pregnancy[10].
Who gets trichomoniasis?
Trichomoniasis affects individuals of all ages who are sexually active, but prevalence is higher among certain groups. Women aged 16–35 years report the highest rates, particularly those with multiple sexual partners or inconsistent condom use. Men often remain asymptomatic carriers, facilitating silent transmission. Risk factors include unprotected sex, history of other STIs (e.g., gonorrhea, chlamydia), and lower socioeconomic status due to limited healthcare access.
Pregnant women are especially vulnerable, as infection raises risks of premature rupture of membranes, low birth weight, and preterm delivery[10]. Immunocompromised individuals, such as those with HIV, face heightened complications, including increased viral shedding and pelvic inflammatory disease. Globally, prevalence exceeds 5% in high-risk populations, with higher rates in developing regions.
What causes trichomoniasis?
The sole causative agent is Trichomonas vaginalis, a pear-shaped, motile protozoan with four anterior flagella and a posterior axostyle for attachment to mucosal surfaces. Measuring 7–30 μm long, it thrives in the alkaline environment of the genital tract (pH >4.5). The parasite adheres to squamous epithelial cells via surface adhesins, evading host immunity through antigenic variation and protease enzymes that degrade mucus and immunoglobulins.
Transmission occurs almost exclusively via direct genital contact during sexual intercourse. Rarely, fomites like shared towels or toilet seats may play a role, but viability outside the body is limited to hours. Vertical transmission during childbirth is possible, though neonatal infections usually resolve spontaneously[10]. Unlike viruses, T. vaginalis does not form cysts, remaining in trophozoite form.
What are the clinical features of trichomoniasis?
Many infections (up to 70–85%) are asymptomatic, allowing undetected spread. When symptomatic, the incubation period ranges from 4–28 days.
In females
Symptoms include a characteristic frothy, yellow-green vaginal discharge with a foul, fishy odor due to amine production by coexisting anaerobes. Patients often report vulval and vaginal itching, dysuria, dyspareunia, and lower abdominal discomfort. Strawberry cervix (punctate hemorrhages on colposcopy) occurs in 2–5% of cases. Discharge may be copious and adherent, with vulval erythema and edema.
In males
Men are less symptomatic, with mild urethritis causing persistent thin discharge, dysuria, or pruritus. Rarely, prostatitis or epididymitis develops.
Complications in women include endometritis, pyosalpinx, infertility, and increased HIV acquisition risk (2–3 fold). In pregnancy, associations with preterm labor and low birth weight are noted[10].
How is trichomoniasis diagnosed?
Diagnosis combines clinical suspicion with laboratory confirmation. Wet mount microscopy reveals motile trichomonads in 50–70% of symptomatic women, but sensitivity drops in men and asymptomatic cases. Nucleic acid amplification tests (NAATs), such as PCR on vaginal/urethral swabs or urine, offer >95% sensitivity and are gold standard.
Culture is more sensitive than microscopy but slower (3–7 days). Point-of-care tests like OSOM Trichomonas Rapid Test detect antigen with 83–97% accuracy. pH >4.5 and positive whiff test (fishy odor on KOH addition) support diagnosis. Routine screening is recommended for high-risk groups, including HIV-positive women.
What is the treatment for trichomoniasis?
Trichomoniasis is curable with nitroimidazole antibiotics. CDC recommends metronidazole 500 mg orally twice daily for 7 days (84–98% cure rate), superior to single 2g dose for preventing reinfection. Alternatives: tinidazole 2g single dose or 7-day multidose.
All sex partners must be treated concurrently (expedited partner therapy) to prevent ping-pong reinfection. Abstain from sex or use condoms for 7 days post-treatment. Resistance occurs in 4–10% of isolates; high-dose tinidazole (2g daily x14 days) or intravaginal paromomycin for failures.
| Regimen | Dose | Duration |
|---|---|---|
| Metronidazole | 500 mg orally BID | 7 days |
| Tinidazole | 2 g orally once | Single dose |
| Metronidazole | 2 g orally once | Single dose (alternative) |
Pregnancy: Metronidazole is safe after first trimester; avoid in first trimester if possible[10]. Avoid alcohol during and 24–72 hours post-nitroimidazoles (disulfiram-like reaction). Topical agents (e.g., clotrimazole) are less effective.
What is the outcome for trichomoniasis?
With adherence, cure rates exceed 90%. Test-of-cure 3 weeks post-treatment if symptoms persist or reinfection suspected, using NAAT. Reinfection is common (10–20%) without partner treatment. Asymptomatic resolution occurs in 20–25%, but treatment prevents complications. Long-term, chronic infection heightens STI/HIV risks.
How can trichomoniasis be prevented?
Prevention hinges on safer sex: consistent male condom use reduces risk by 50–70%. Mutual monogamy with uninfected partners, routine STI screening, and partner notification are key. No vaccine exists, but education on symptoms and prompt testing aids control. Avoid douching, which disrupts vaginal flora. High-risk individuals benefit from pre-exposure metronidazole prophylaxis in some settings.
Related topics - Bacterial vaginosis
- Candidiasis
- Gonorrhoea
- Pubic lice
- Scabies
Frequently asked questions
Can trichomoniasis be cured?
Yes, trichomoniasis is curable with a course of antibiotics like metronidazole or tinidazole, achieving over 90% cure rates when partners are treated concurrently.
How long does trichomoniasis last without treatment?
Untreated infections can persist for months to years, with spontaneous resolution in 20–25% of cases, but treatment is essential to prevent complications and transmission.
Is trichomoniasis dangerous during pregnancy?
It increases risks of preterm birth and low birth weight; metronidazole is safe after the first trimester[10].
Can men get trichomoniasis?
Yes, though often asymptomatic; they can transmit it and require treatment.
Does trichomoniasis cause infertility?
Chronic untreated cases may contribute to pelvic inflammatory disease and infertility in women.
References
- Trichomoniasis and Other Sexually Transmitted Parasitic Diseases — National Center for Biotechnology Information (PMC). 2024. https://pmc.ncbi.nlm.nih.gov/articles/PMC12147518/
- Trichomoniasis – NHS — National Health Service. 2023-10-24. https://www.nhs.uk/conditions/trichomoniasis/
- Trichomoniasis – Symptoms & causes — Mayo Clinic. 2023-11-01. https://www.mayoclinic.org/diseases-conditions/trichomoniasis/symptoms-causes/syc-20378609
- Trichomoniasis Fact Sheet — TRICARE Portsmouth. 2022. https://portsmouth.tricare.mil/Portals/130/Trichomoniasis.pdf
- Trichomoniasis – DermNet — DermNet NZ. 2024. https://dermnetnz.org/topics/trichomoniasis
- Trichomonas: Expedited Partner Therapy (EPT) — Nationwide Children’s Hospital. 2023. https://www.nationwidechildrens.org/conditions/ept-trichomoniasis
- Trichomoniasis – STI Treatment Guidelines — Centers for Disease Control and Prevention (CDC). 2021-07-22. https://www.cdc.gov/std/treatment-guidelines/trichomoniasis.htm
Similar Articles
Read full bio of Sneha Tete
